Taylor Wessing advises PanOpSys Limited on $5.25 million Series A funding with Quester

08-Mar-2006  |  Corporate, Employment & Pensions, Intellectual Property

CLIENT

PanOpSys

VALUE

$5.25 million

TRANSACTION

Series A funding round

DESCRIPTION

The venture capital group at European law firm, Taylor Wessing, has advised PanOpSys Limited, a medical diagnostics company focusing on rapid quantitative detection of disease markers, on the raising of $5.25 million following a Series A funding from Quester.